Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments.
Mitchell M MoosaviAbigail L GoodmanAlexander DuncanSean R StowellEdmund K WallerJohn D RobackHarold C SullivanPublished in: Journal of clinical apheresis (2020)
IDA is a risk of chronic ECP therapy and is likely secondary to retained blood components in the instrument. The temporal relationship between anemia and ECP treatment has a direct correlation with the treatment schedule. Patients undergoing ECP treatment should be closely monitored for the development of IDA.